The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $100.37

Today's change-3.88 -3.72%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $100.37

Today's change-3.88 -3.72%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc crosses below 20-day moving average

Abiomed Inc closed sharply lower Friday, dropping (U.S.)$3.88 or 3.72% to (U.S.)$100.37 and crossing below its 20-day moving average. Over the last five days, shares have gained 1.15% and 11.18% year to date. Shares have outperformed the S&P 500 by 53.97% during the last year.

Key company metrics

  • Open(U.S.) $99.00
  • Previous close(U.S.) $104.25
  • High(U.S.) $103.98
  • Low(U.S.) $98.01
  • Bid / Ask(U.S.) $98.80 / (U.S.) $0.00
  • YTD % change+11.18%
  • Volume4,664,903
  • Average volume (10-day)496,829
  • Average volume (1-month)437,656
  • Average volume (3-month)586,820
  • 52-week range(U.S.) $64.03 to (U.S.) $110.68
  • Beta1.10
  • Trailing P/E118.08×
  • P/E 1 year forward90.68×
  • Forward PEG3.30×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.85
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue94867673
Total other revenue--------
Total revenue94867673
Gross profit79736463
Total cost of revenue15131211
Total operating expense74686458
Selling / general / administrative45424037
Research & development14141210
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income20171315
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax20171315
Income after tax111189
Income tax, total9756
Net income111189
Total adjustments to net income--------
Net income before extra. items111189
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items111189
Inc. avail. to common incl. extra. items111189
Diluted net income111189
Dilution adjustment--------
Diluted weighted average shares45454544
Diluted EPS excluding extraordinary itemsvalue per share0.240.230.170.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.240.230.170.20